论文部分内容阅读
64例初诊T2DM患者随机分为两组,各32例,A组(门冬胰岛素30组)及B组(诺和灵30R组),比较两组治疗12周后FBG、PBG、GHbA1c、血糖达标所需时间、血糖达标时胰岛素用量及低血糖的情况。结果结果2种预混胰岛素方法均可使血糖达标,A组较B组显著降低(P<0.01或P<0.05);A组血糖达标所需时间和所需胰岛素用量明显少于B组(P<0.01或P<0.05)。A组低血糖发生次数为6.67%,B组低血糖发生次数为20.0%。结论对于初诊T2DM患者,应用门冬胰岛素30注射液疗效优于诺和灵30R注射液,可较理想控制全天血糖。
Sixty-four newly diagnosed T2DM patients were randomly divided into two groups (n = 32 in each group), group A (aspart insulin 30) and group B (noradren 30R). FBG, PBG, GHbA1c, The time required, the amount of insulin when blood glucose and hypoglycemia. Results The blood glucose levels of two kinds of premixed insulin methods were all achieved. The blood glucose level of group A was significantly lower than that of group B (P <0.01 or P <0.05). The time required for glycemic control and the required amount of insulin in group A were significantly lower than those of group B <0.01 or P <0.05). The incidence of hypoglycemia in group A was 6.67% and the incidence of hypoglycemia in group B was 20.0%. Conclusions For asymptomatic T2DM patients, the application of insulin aspart 30 injection is superior to that of Norinol 30R injection, which can be a better control of whole blood glucose.